Menu
Logo

Covid-19 Vaccine

For Covid-19 Vaccine Information

Please use the contact details below:

Phone: +358981710294 (local language)

Email: jgcc_emea@its.jnj.com

or

Visit our COVID-19 vaccine site to access following information:

  • Patient Information Leaflet (PIL)
  • Vaccination card
  • Summary of Product Characteristics (SmPC)
  • Storage, Dosage & Administration
  • Adverse event and product quality compliant reporting

EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome:

https://www.ema.europa.eu/en/news/ema-raises-awareness-clinical-care-recommendations-manage-suspected-thrombosis-thrombocytopenia

Visit Janssen.com/finland to read more about Janssen Finland and our work against COVID-19.
2021-03-11 | EM-56027